![]() |
市場調查報告書
商品編碼
2169906
眼部護理產品市場:預測(至 2034 年)-按產品類型、主要關注點、活性成分、分銷管道、消費者年齡層和地區進行全球分析。Under-Eye Care Products Market Forecasts to 2034 - Global Analysis By Product Type (Eye Creams, Eye Serums, Eye Gels, Eye Masks and Patches, and Eye Roll-Ons), Primary Concern, Active Ingredient, Distribution Channel, Consumer Age and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球眼部護理產品市場規模將達到 42 億美元,並在預測期內以 7.5% 的複合年成長率成長,到 2034 年將達到 75 億美元。
眼部護理產品是指專為眼周嬌嫩肌膚設計的局部外用配方,旨在減少疲勞和老化的可見徵兆。這些產品利用強效血管收縮劑、保濕劑和細胞活化成分,來減輕浮腫、促進膠原蛋白合成並改善微循環。產品形式包括乳霜、精華液、凝膠和貼片,透過日常護膚,發揮針對性的皮膚護理功效,例如淡化黑眼圈、撫平細紋並提升眼周肌膚的整體活力。
螢幕疲勞加劇
隨著全球對眼部健康的日益關注,消費者越來越傾向於選擇能夠可靠、精準緩解眼部疲勞的先進眼部健康產品。消費者對實際效果和即時消除眼部浮腫的需求不斷成長,正加速這些智慧配方融入日常護膚。這項轉變得益於生物活性成分技術的進步,該技術能夠增強肌膚的持久活力。因此,製造商正投資研發專業的輸送系統,以滿足嚴格的功效標準,同時最佳化消費者的長期滿意度和整體肌膚健康。
高階配方高成本
高階眼部護理產品的高昂成本是其商業性推廣的主要障礙。複雜的生化配方通常需要嚴格的臨床試驗和專家穩定性評估,這推高了整體生產成本。此外,個體皮膚耐受性的差異導致產品需要頻繁更換,這限制了對特定產品類型功效的評估。這些因素共同限制了此類產品的商業性擴張,尤其是在全球對價格敏感、尋求快速起效且經濟實惠的眼部護理解決方案的消費者群體中。
含胜肽美容精華液的擴張
在臨床美容領域,消費者對以實證醫學為基礎、高效護膚產品的日益青睞,為眼部護理產品公司帶來了巨大的成長機會。以胜肽為基礎的療法,採用先進的仿生化合物和天然萃取物作為主要成分,無需侵入性手術即可高效滋養肌膚健康,最佳化膠原蛋白生成。隨著全球對皮膚科醫療基礎設施的投資不斷擴大,監管機構也越來越重視以實證醫學為基礎的化妝品核准流程,預計先進胜肽解決方案的應用將顯著成長。
與美容手術的競爭
對替代性皮膚病學調查方法的持續依賴對傳統局部局部護理產品構成了重大威脅。注射填充劑和先進雷射治療等新型臨床療法,在某些醫療條件下通常能提供更高的精準度、更快的見效速度和更顯著的效果,使其成為應對嚴重衰老跡象更具經濟效益的選擇。此外,美容技術的快速發展也提高了傳統皮膚再生方法的效率。這種競爭壓力可能會阻礙產品在以臨床療效為首要考慮的市場中的滲透。
疫情初期,由於物流限制和門市關閉,個人保健產品的供應鏈受到衝擊,導致部分零售訂單延遲。然而,隨後居家自我護理的興起加速了非處方外用保健產品作為日常必需品的普及。疫情後,人們對整裝儀容的興趣日益濃厚,推動了對高階眼部護理產品的長期投資,進而促進了強勁的商業性復甦,並在全球不同消費群體中實現了持續擴張。
在預測期內,眼霜細分市場預計將佔據最大的市場佔有率。
由於眼霜易於取得且在日常護膚程序中已被證實有效,預計在預測期內,眼霜細分市場將佔據最大的市場佔有率。眼霜配方具有卓越的生物相容性,能夠有效地將活性成分輸送到眼周肌膚,適用於各種膚質,顯著簡化了塗抹步驟,並最大限度地提高了用戶在日常護膚程序中的堅持率。隨著消費者越來越重視擴充性、經濟高效且針對性強的解決方案,對專業保濕霜的需求持續成長,鞏固了該細分市場的領先地位。
預計在預測期內,肽類細分市場將呈現最高的複合年成長率。
在預測期內,胜肽類產品預計將呈現最高的成長率,這主要得益於化妝品化學研究的快速發展和超高純度仿生萃取方法。這些創新技術能夠精準遞送強效的膠原蛋白刺激因子,進而為敏感的眼周肌膚帶來高度專業化、強效的煥膚效果。透過先進的胜肽整合技術,促進細胞穩定性、組織修復和深層結構重建,顯著提升了整體健康功效,並加速了其在全球的商業性推廣。
在預測期內,北美預計將佔據最大的市場佔有率,這得益於其成熟的個人護理產業和先進的皮膚病學基礎設施,這些設施廣泛使用專業治療產品。該地區受益於大量的研發投入、強力的智慧財產權保護以及旨在提升整體皮膚健康的消費者意識宣傳活動。此外,美國和加拿大的主要產業參與者率先採用先進的局部治療方案,進一步鞏固了其全球主導地位。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於新興經濟體的快速經濟現代化和個人護理行業的擴張。中國、印度和韓國等國家正在加大對先進護膚基礎設施和創新治療技術的投資,以滿足國內日益成長的美容需求。此外,有利的政府政策、不斷成長的外國直接投資以及成本效益高的生產資源正在加速全部區域眼部護理產品的普及。
According to Stratistics MRC, the Global Under-Eye Care Products Market is accounted for $4.2 billion in 2026 and is expected to reach $7.5 billion by 2034 growing at a CAGR of 7.5% during the forecast period. Under-eye care products refer to specialized topical formulations designed to target the delicate periorbital area by reducing visible signs of fatigue and aging. These solutions function by utilizing potent vasoconstrictors, hydrating humectants, and cellular stimulators to diminish fluid retention, promote collagen synthesis, and enhance microcirculation. They encompass creams, serums, gels, and patches that deliver targeted dermatological benefits for alleviating dark circles, smoothing fine lines, and ensuring overall ocular vitality during daily personal care routines.
Rising Prevalence of Screen Fatigue
The escalating global emphasis on ocular wellness compels consumers to adopt advanced under-eye products offering reliable and targeted fatigue reduction alternatives. Growing demand for operational efficiency and real-time depuffing is accelerating the integration of these smart formulations into daily routines. This transition is supported by advancements in bioactive ingredient technology, which enhances long-lasting revitalizing capabilities. Consequently, manufacturers invest in specialized delivery systems to achieve compliance with stringent efficacy benchmarks while optimizing long-term consumer satisfaction and overall skin health.
High Costs of Premium Formulations
The substantial expenses associated with acquiring advanced premium under-eye treatments represent a significant barrier to widespread commercial adoption. Formulating complex biochemical combinations often requires rigorous clinical testing and specialized stability assessments, which escalate overall production costs. Furthermore, the continuous need for product rotation due to variable individual skin tolerances limits the perceived efficacy of certain treatment types. These factors collectively constrain commercial expansion, particularly for price-sensitive demographics seeking immediate and cost-effective revitalization solutions globally.
Expansion in Peptide-Based Serums
The clinical beauty sector presents substantial growth opportunities for under-eye providers due to increasing consumer preference for science-backed and high-performance skincare products. Peptide-integrated treatments offer a highly effective pathway to nourish skin health and optimize collagen production without invasive procedures, utilizing advanced biomimetic compounds and natural extracts as primary inputs. As global investments in dermatological infrastructure expand and regulatory agencies favor evidence-based cosmetic pathways, the adoption of advanced peptide solutions is expected to surge significantly.
Competition from Aesthetic Procedures
The continuous reliance on alternative dermatological methodologies poses a considerable threat to traditional topical under-eye treatments. Emerging clinical procedures such as injectable fillers and advanced laser therapies often exhibit superior precision and faster visible results under specific medical conditions, making them more economically viable for severe aging cases. Additionally, the rapid advancement of aesthetic technology enhances the efficiency of conventional skin restoration methods. This competitive pressure may hinder product penetration where ultimate clinical efficacy is the primary consumer consideration.
The pandemic initially disrupted personal care supply chains and delayed elective retail purchases due to logistical constraints and store shutdowns. However, the subsequent shift toward home-based self-care routines accelerated the adoption of over-the-counter topical wellness solutions for essential daily maintenance. Post-pandemic, the heightened focus on personal grooming has reinforced long-term investments in advanced under-eye products, driving robust commercial recovery and sustained expansion across diverse consumer demographics globally.
The Eye Creams segment is expected to be the largest during the forecast period
The Eye Creams segment is expected to account for the largest market share during the forecast period, due to their widespread accessibility and proven efficacy in daily revitalization regimens. Cream formulations offer exceptional biological compatibility and deliver active under-eye ingredients effectively across diverse skin profiles, which significantly reduces usage friction and maximizes user compliance in daily routines. As consumers increasingly prioritize scalable and cost-effective targeted solutions, the demand for specialized hydrating creams continues to surge, thereby solidifying their dominant position.
The Peptides segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Peptides segment is predicted to witness the highest growth rate, driven by rapid advancements in cosmetic chemistry research and ultra-pure biomimetic extraction methodologies. These innovative technologies enable the precise delivery of powerful collagen stimulators to produce highly specialized and robust rejuvenation outputs tailored for sensitive periorbital applications. The ability to enhance cellular stability, tissue repair, and deep structural recovery through advanced peptide integration significantly improves overall wellness economics, accelerating widespread commercial adoption globally.
During the forecast period, the North America region is expected to hold the largest market share, due to the presence of well-established personal care industries and advanced dermatological infrastructure that heavily utilize specialized treatment products. The region benefits from substantial research and development investments, robust intellectual property protection, and supportive consumer awareness initiatives promoting holistic skin health. Furthermore, the early adoption of advanced topical therapies by key industry players in the United States and Canada reinforces the dominant position globally.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapid economic modernization and expanding personal care sectors in emerging economies. Countries such as China, India, and South Korea are increasingly investing in advanced skincare infrastructure and innovative treatment technologies to meet growing domestic beauty demands. Additionally, favorable government policies, rising foreign direct investment, and cost-effective manufacturing resources are collectively driving the accelerated adoption of under-eye products across the region.
Key players in the market
Some of the key players in Global Under-Eye Care Products Market include L'Oreal S.A., The Estee Lauder Companies Inc., Beiersdorf AG, Shiseido Company, Limited, Kenvue Inc., Procter & Gamble Company, Unilever PLC, Kao Corporation, Amorepacific Corporation, LG H&H Co., Ltd., Coty Inc., e.l.f. Beauty, Inc., Natura &Co Holding S.A., Galderma Group AG, Pierre Fabre Laboratories, Clarins Group, LVMH Moet Hennessy Louis Vuitton SE, and Rohto Pharmaceutical Co., Ltd.
In October 2026, Rohto Pharmaceutical Co., Ltd. launched a next-generation peptide serum optimized for daily ocular recovery, achieving clinically validated firmness improvements while significantly reducing application time for global skincare consumers.
In September 2026, Pierre Fabre Laboratories expanded its premium under-eye production capacity through a strategic partnership with a leading biotech firm, enabling the scalable deployment of novel botanical formulations for sensitive skin care.
In August 2026, e.l.f. Beauty, Inc. inaugurated a new state-of-the-art personal care research facility in Asia, focusing on the discovery and optimization of natural plant extracts for the expanding global skincare markets.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.